United Health Products Changes Principal Executive Offices
Ticker: UEEC · Form: 8-K · Filed: Nov 6, 2024 · CIK: 1096938
| Field | Detail |
|---|---|
| Company | United Health Products, INC. (UEEC) |
| Form Type | 8-K |
| Filed Date | Nov 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: administrative, address-change
TL;DR
UHP moved its HQ to Mt. Laurel, NJ effective Nov 4.
AI Summary
United Health Products, Inc. filed an 8-K on November 6, 2024, reporting an event that occurred on November 4, 2024. The filing indicates the company's principal executive offices are now located at 520 Fellowship Road, Suite #D-406, Mt. Laurel, NJ 08054. This change in address was effective as of November 4, 2024.
Why It Matters
A change in principal executive offices can indicate operational shifts or restructuring within the company. Investors should monitor if this move is associated with other significant business developments.
Risk Assessment
Risk Level: low — This filing is a routine administrative update regarding the company's address and does not involve financial performance or strategic changes.
Key Players & Entities
- United Health Products, Inc. (company) — Registrant
- November 4, 2024 (date) — Effective date of address change
- November 6, 2024 (date) — Filing date
- 520 Fellowship Road, Suite #D-406, Mt. Laurel, NJ 08054 (location) — New principal executive offices
FAQ
What is the new address for United Health Products, Inc.'s principal executive offices?
The new address is 520 Fellowship Road, Suite #D-406, Mt. Laurel, NJ 08054.
When did the change in principal executive offices become effective?
The change became effective on November 4, 2024.
What type of filing is this for United Health Products, Inc.?
This is a Form 8-K, a Current Report.
What was the previous location of the principal executive offices?
The filing does not explicitly state the previous address, only the new one.
Is this filing related to a specific event or transaction?
This filing is categorized under 'Other Events' and concerns the change of the company's principal executive offices.
Filing Stats: 459 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-11-06 13:52:13
Filing Documents
- ueec_8k.htm (8-K) — 24KB
- ueec_ex991.htm (EX-99.1) — 9KB
- 0001477932-24-006902.txt ( ) — 148KB
- ueec-20241104.xsd (EX-101.SCH) — 6KB
- ueec-20241104_lab.xml (EX-101.LAB) — 13KB
- ueec-20241104_cal.xml (EX-101.CAL) — 1KB
- ueec-20241104_pre.xml (EX-101.PRE) — 8KB
- ueec-20241104_def.xml (EX-101.DEF) — 2KB
- ueec_8k_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On November 4, 2024, the United Health Products, Inc. issued a press release announcing an update on the FDA's Premarket Approval application for the company's HemoStyp Gauze. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. We refer you to the risk factors in Part II Item 1A of the company's Quarterly Report on Form 10-Q for the period ended June 30, 2024 for a discussion of the risks relating to our Premarket Approval application.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release, dated November 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. United Health Products, Inc. Dated: November 6, 2024 By: /s/ Brian Thom Brian Thom Chief Executive Officer 3